We report for the first time the genetic and biological characterization of 10 HIV-1 primary isolates representing CRF28_BF and CRF29_BF together with additional unique BF recombinant forms (URFs) obtained by PBMC cocultivation. Recombination is an important factor promoting the increase in the genetic diversity of HIV-1. Notably, more than 20% of HIV-1 sequences worldwide were recombinants. Several recombinant viruses were reported in Brazil, and six circulating recombinant forms (CRFs) have been identified (CRF28_BF, CRF29_BF, CRF31_BC, CRF39_BF, CRF40_BF, and CRF46_BF). CRF28_BF and CRF29_BF were found to infect almost 30% of the patients in São Paulo State. The near full-length genomes of these 10 primary isolates were amplified by nested PCR in three overlapping segments, purified, and sequenced. Three samples were related to CRF28_BF, three to CRF29_BF, and four were unique recombinant forms (URFs), as determined by their breakpoint profile determined with the jpHMM program. Additionally, the coreceptor usage of these isolates was investigated in vitro using GHOST assays, which revealed three dual-tropic (X4/R5) viruses, four lymphotropic (X4) viruses, and three macrophage-tropic (R5) viruses with different V3-loop motifs, which challenges the notion that GWGR-carrying viruses are macrophage-tropic only. In sum, we report a much-anticipated well-characterized panel of viruses representing CRF28_BF, CRF29_BF, and URFs from São Paulo State, Brazil.
Get full access to this article
View all access options for this article.
References
1.
TaylorBS, SobieszczykME, McCutchanFE, HammerSM. The challenge of HIV-1 subtype diversity. N Engl J Med, 2008; 358,15:1590–1602.
2.
PapathanasopoulosMA, HuntGM, TiemessenCT. Evolution and diversity of HIV-1 in Africa—a review. Virus Genes, 2003; 26,2:151–163.
3.
McCutchanFE. Understanding the genetic diversity of HIV-1. AIDS, 2000; 14,Suppl 3:S31–S44.
4.
CockKM, WeissHA. The global epidemiology of HIV/AIDS. Trop Med Int Health, 2000; 5,7:A3–A9.
5.
HamersFF, DownsAM, InfusoA, BrunetJB. Diversity of the HIV/AIDS epidemic in Europe. AIDS, 1998; 12,Suppl A:S63–S70.
HoDD, NeumannAU, PerelsonAS, ChenW, LeonardJM, MarkowitzM. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature, 1995; 373,6510:123–126.
10.
NeherRA, LeitnerT. Recombination rate and selection strength in HIV intra-patient evolution. PLoS Comput Biol, 2010; 6,1:e1000660.
11.
RamirezBC, Simon-LoriereE, GalettoR, NegroniM. Implications of recombination for HIV diversity. Virus Res, 2008; 134,1–2:64–73.
12.
AroraP, DixitNM. Timing the emergence of resistance to anti-HIV drugs with large genetic barriers. PLoS Comput Biol, 2009; 5,3:e1000305.
13.
StreeckH, LiB, PoonAFet al.Immune-driven recombination and loss of control after HIV superinfection. J Exp Med, 2008; 205,8:1789–1796.
14.
NoraT, CharpentierC, TenaillonO, HoedeC, ClavelF, HanceAJ. Contribution of recombination to the evolution of human immunodeficiency viruses expressing resistance to antiretroviral treatment. J Virol, 2007; 81,14:7620–7628.
15.
CharpentierC, NoraT, TenaillonO, ClavelF, HanceAJ. Extensive recombination among human immunodeficiency virus type 1 quasispecies makes an important contribution to viral diversity in individual patients. J Virol, 2006; 80,5:2472–2482.
16.
MoutouhL, CorbeilJ, RichmanDD. Recombination leads to the rapid emergence of HIV-1 dually resistant mutants under selective drug pressure. Proc Natl Acad Sci USA, 1996; 93,12:6106–6111.
17.
OsmanovS, PattouC, WalkerN, SchwardlanderB, EsparzaJ. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J Acquir Immune Defic Syndr, 2002; 29,2:184–190.
18.
HemelaarJ, GouwsE, GhysP, OsmanovS. Characterisation WUNfHIa. Global trends in molecular epidemiology of HIV-1 during 2000–2007. IAS, ed. XVIII International AIDS ConferenceVol Abstract no. THAA0201.Vienna Austria, 2010.
19.
HemelaarJ, GouwsE, GhysPD, OsmanovS. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS, 2006; 20,16:W13–W23.
20.
GaoF, RobertsonDL, MorrisonSGet al.The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol, 1996; 70,10:7013–7029.
21.
MontavonC, Toure-KaneC, LiegeoisFet al.Most env and gag subtype A HIV-1 viruses circulating in West and West Central Africa are similar to the prototype AG recombinant virus IBNG. J Acquir Immune Defic Syndr, 2000; 23,5:363–374.
22.
AnderssonS, NorrgrenH, DiasF, BiberfeldG, AlbertJ. Molecular characterization of human immunodeficiency virus (HIV)-1 and -2 in individuals from Guinea-Bissau with single or dual infections: Predominance of a distinct HIV-1 subtype A/G recombinant in West Africa. Virology, 1999; 262,2:312–320.
23.
ZhangM, FoleyB, SchultzAKet al.The role of recombination in the emergence of a complex and dynamic HIV epidemic. Retrovirology, 2010; 7:25.
24.
BelloG, AulicinoPC, RuchanskyDet al.Phylodynamics of HIV-1 circulating recombinant forms 12_BF and 38_BF in Argentina and Uruguay. Retrovirology, 2010; 7:22.
25.
AulicinoPC, HolmesEC, RoccoC, ManganoA, SenL. Extremely rapid spread of human immunodeficiency virus type 1 BF recombinants in Argentina. J Virol, 2007; 81,1:427–429.
26.
TurkG, CarobeneM, MonczorA, RubioAE, Gomez-CarrilloM, SalomonH. Higher transactivation activity associated with LTR and Tat elements from HIV-1 BF intersubtype recombinant variants. Retrovirology, 2006; 3:14.
27.
De CandiaC, EspadaC, DuetteGet al.Viral replication is enhanced by an HIV-1 intersubtype recombination-derived Vpu protein. Virol J, 2010; 7,1:259.
28.
de SouzaAC, de OliveiraCM, RodriguesCL, SilvaSA, LeviJE. Molecular characterization of HIV type 1 BF pol recombinants from Sao Paulo, Brazil. AIDS Res Hum Retroviruses, 2008; 24,12:1521–1525.
29.
TeixeiraD, MuneratoP, KomninakisSCet al.The detection of in vivo and in vitro HIV type 1 B/F profiles in Brazil using a real-time PCR assay for five HIV type 1 genomic regions. AIDS Res Hum Retroviruses, 2010; 26,9:981–990.
HollingerFB, BremerJW, MyersLE, GoldJW, McQuayL. Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories. J Clin Microbiol, 1992; 30,7:1787–1794.
32.
NadaiY, EyzaguirreLM, ConstantineNTet al.Protocol for nearly full-length sequencing of HIV-1 RNA from plasma. Plos One, 2008; 3,1:e1420.
33.
ZhangM, SchultzAK, CalefCet al.jpHMM at GOBICS: A web server to detect genomic recombinations in HIV-1. Nucleic Acids Res, 2006; 34:W463–W465.
34.
SchultzAK, ZhangM, LeitnerTet al.A jumping profile hidden Markov model and applications to recombination sites in HIV and HCV genomes. BMC Bioinformatics, 2006; 7:265.
35.
SchultzAK, ZhangM, BullaIet al.jpHMM: Improving the reliability of recombination prediction in HIV-1. Nucleic Acids Res, 2009; 37:W647–W651.
36.
SanchezV, MasiaM, RobledanoC, PadillaS, RamosJM, GutierrezF. Performance of genotypic algorithms for predicting HIV-1 tropism measured against the enhanced-sensitivity Trofile coreceptor tropism assay. J Clin Microbiol, 2010; 48,11:4135–4139.
37.
MornerA, BjorndalA, AlbertJet al.Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage. J Virol, 1999; 73,3:2343–2349.
38.
HendrixCW, FlexnerC, MacFarlandRTet al.Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother, 2000; 44,6:1667–1673.
39.
De ClercqE, YamamotoN, PauwelsRet al.Highly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100. Antimicrob Agents Chemother, 1994; 38,4:668–674.
40.
BridgerGJ, SkerljRT, ThorntonDet al.Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-tetraazamacrocycles that inhibit HIV replication. Effects of macrocyclic ring size and substituents on the aromatic linker. J Med Chem, 1995; 38,2:366–378.
41.
AltschulSF, MaddenTL, SchafferAAet al.Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res, 1997; 25,17:3389–3402.
42.
De Sa FilhoDJ, SucupiraMC, CaseiroMM, SabinoEC, DiazRS, JaniniLM. Identification of two HIV type 1 circulating recombinant forms in Brazil. AIDS Res Hum Retroviruses, 2006; 22,1:1–13.
43.
SanabaniS, Kleine NetoW, KalmarEM, DiazRS, JaniniLM, SabinoEC. Analysis of the near full length genomes of HIV-1 subtypes B, F and BF recombinant from a cohort of 14 patients in Sao Paulo, Brazil. Infect Genet Evol, 2006; 6,5:368–377.
44.
LealE, VillanovaFE. Diversity of HIV-1 subtype B: Implications to the origin of BF recombinants. PLoS One, 2010; 5,7:e11833.
45.
FouchierRA, GroeninkM, KootstraNAet al.Phenotype-associated sequence variation in the third variable domain of the human immunodeficiency virus type 1 gp120 molecule. J Virol, 1992; 66,5:3183–3187.
46.
SabinoEC, ShpaerEG, MorgadoMGet al.Identification of human immunodeficiency virus type 1 envelope genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil. J Virol, 1994; 68,10:6340–6346.
47.
LealE, MartinsLO, JaniniLM, DiazRS. Evolutionary dynamics of HIV-1 BF and CB recombinants and its parental counterparts in South America. Retrovirol: Res Treat, 20082008(RRT-1-Leal-et-al):1.
48.
PiantadosiA, ChohanB, ChohanV, McClellandRS, OverbaughJ. Chronic HIV-1 infection frequently fails to protect against superinfection. PLoS Pathog, 2007; 3,11:e177.
49.
SanabaniS, PastenaE, NetoW, MartinezV, SabinoE. Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in Sao Paulo, Brazil. Virol J, 2010; 7:74.
50.
JavaherianK, LangloisAJ, LaRosaGJet al.Broadly neutralizing antibodies elicited by the hypervariable neutralizing determinant of HIV-1. Science, 1990; 250,4987:1590–1593.
51.
KmieciakD, WasikTJ, TepplerHet al.The effect of deletion of the V3 loop of gp120 on cytotoxic T cell responses and HIV gp120-mediated pathogenesis. J Immunol, 1998; 160,11:5676–5683.
52.
FerraroGA, MelloMAG, SutmollerFet al.Biological characterization and chemokine receptor usage of HIV type 1 isolates prevalent in Brazil. Aids Res Hum Retroviruses, 2001; 17,13:1241–1247.
53.
LealE, SilvaWP, SucupiraMC, JaniniLM, DiazRS. Molecular and structural characterization of HIV-1 subtype B Brazilian isolates with GWGR tetramer at the tip of the V3-loop. Virology, 2008; 381,2:222–229.
54.
Tomasini-GrottoR-M, MontesB, TrigliaDet al.Variability of the conserved V3 loop tip motif in HIV-1 subtype B isolates collected from Brazilian and French patients. Brazilian J Microbiol, 2010; 41:720–728.
55.
BrusellesA, RozeraG, BartoliniBet al.Use of massive parallel pyrosequencing for near full-length characterization of a unique HIV Type 1 BF recombinant associated with a fatal primary infection. AIDS Res Hum Retroviruses, 2009; 25,9:937–942.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
